Mounjaro News

Eli Lilly Expands Horizons: Launching Revolutionary Weight Loss Drug in China and India

Eli Lilly & Co. plans to introduce Mounjaro, its diabetes and weight-loss medication, in China, India, Brazil, and Mexico, targeting up to 900 million patients. The move comes as d...

Eli Lilly Predicts Robust Revenue Growth, Eyes $58-61 Billion by 2025

Eli Lilly and Company forecasts a significant revenue increase to $58-61 billion by 2025, driven by strong sales of its diabetes and obesity treatments, Mounjaro and Zepbound. CEO ...